About Zoetis Pharmaceutical Research Private Limited
Data last updated:
Zoetis Pharmaceutical Research Private Limited is a foreign private limited company based in Mumbai, Maharashtra, India, a subsidiary of Pah India Holding 1 B.V. It operates in the pharma contract r and d segment of the pharmaceuticals sector. It was incorporated on 02 January 1995 and has been in existence for over 31 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U24117MH1995FTC084206. Its GSTIN is 27AADCP5293L2ZV (Maharashtra). The company holds 4 GST registrations, of which 1 is active.
The company has an authorised share capital of ₹700 Cr and a paid-up capital of ₹354.24 Cr. It was formerly known as Warner-Lambert India Private Limited and Warner-Lambert India Limited. It is led by directors including Anurag Sood (Whole-Time Director) and Sudeepta Neogi (Whole-Time Director).
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at 31 3rd Floor Kalpataru Synergy Opp. : Grand Hyatt Santacruz(E), Mumbai, Maharashtra, India – 400055.
As per the financials filed for FY 2025, the company reported a revenue of ₹595.44 Cr, a growth of 28% compared to the previous year. For the same year it recorded a net profit of ₹41.59 Cr (net margin 7%) and EBITDA of ₹105.87 Cr (EBITDA margin 17.8%). Revenue has grown at a compounded annual rate (CAGR) of 18% over three years and 12% over five years.
The company has about 53 employees on its provident fund (EPFO) records. Its group structure includes 1 subsidiary.
The company is associated with 1 brand: Zoetis. As per MCA filings, the company has open charges of ₹75.25 Cr on record. Court records list 11 cases involving the company, including 9 filed by the company and 2 filed against it; 2 cases are pending. The company has 3 deals on record (2 funding rounds, 1 secondary share transfer), with disclosed funding of ₹1,127.66 Cr; the latest was in November 2012. The company has 6 MSME Form 1 returns on record between 2019 and 2024, listing 43 overdue payments to 17 micro and small suppliers.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website zoetis.in.
Company details
Name history
Zoetis Pharmaceutical Research has undergone 3 name changes throughout its history. The company was previously known as Warner-Lambert India Private Limited, Warner-Lambert India Limited, and Pfizer Pharmaceutical India Private Limited. The current legal name is Zoetis Pharmaceutical Research Private Limited.
| Company Name | Status |
|---|---|
| Zoetis Pharmaceutical Research Private Limited | Current |
| Warner-Lambert India Private Limited | Previous |
| Warner-Lambert India Limited | Previous |
| Pfizer Pharmaceutical India Private Limited | Previous |
CIN history
Zoetis Pharmaceutical Research has one previous CIN (Corporate Identification Number): U24117MH1995PTC084206. The current CIN is U24117MH1995FTC084206, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U24117MH1995FTC084206 | Current |
| U24117MH1995PTC084206 | Previous |
Contact details
Zoetis Pharmaceutical Research Private Limited's registered office is in Mumbai, Maharashtra. Its website is zoetis.in. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Social Media
- Registered Address31 3rd Floor Kalpataru Synergy Opp. : Grand Hyatt Santacruz(E), Mumbai, Maharashtra, India – 400055
- IndustryPharma, Pharma Contract R&D
To see the full contact details of Zoetis Pharmaceutical Research Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Brands
Zoetis Pharmaceutical Research operates one associated brand: Zoetis. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Animal medicines, vaccines, and diagnostics are manufactured and supplied. | zoetis.com |
Business activity
The main business activity of Zoetis Pharmaceutical Research is professional, scientific and technical. In detail, this covers scientific research and development.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| M | Professional, Scientific and Technical | M5 | Scientific research and development |
To see the full business activity and turnover split of Zoetis Pharmaceutical Research Private Limited, buy the company report.
Financials of Zoetis Pharmaceutical Research Private Limited
FY 2024 filings availableZoetis Pharmaceutical Research Private Limited reported revenue of ₹595.44 Cr (up 28% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 12% over five years, including 28% growth in the latest year. EBITDA rose 73% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹105.87 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹41.59 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 17.8% | ||||
| Net Profit Margin | 7% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Zoetis Pharmaceutical Research Private Limited, buy the company report.
Board of directors of Zoetis Pharmaceutical Research Private Limited
Zoetis Pharmaceutical Research has 4 current directors and 20 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Anurag Sood | Whole-Time Director | 06 Mar 2023 | 3 Years 8 Months | Current |
| Sudeepta Neogi | Whole-Time Director | 26 Mar 2021 | 5 Years 7 Months | Current |
| Kavita Kirankumar Bhavnani | Director | 24 Nov 2012 | 13 Years 11 Months | Current |
| Deepak Mohanlal Jain | Whole-Time Director | 14 Nov 2022 | 3 Years 11 Months | Current |
Auditor
Zoetis Pharmaceutical Research Private Limited is audited by MSKA & ASSOCIATES for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| MSKA & ASSOCIATES | FY 2023 | 105047W |
Shareholding
The shareholding of Zoetis Pharmaceutical Research Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Zoetis Pharmaceutical Research Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 27 Jul 1998 | 90160958 | Anz Grindlays Bank Ltd. | ₹25.75 Cr | Open | |
| 27 Jul 1998 | 90163748 | Anz Grindlays Bank Ltd. | ₹25.75 Cr | Open | |
| 10 Oct 1995 | 90166403 | The Hongkong and Shangai Bank Co.Ltd. | ₹15.75 Cr | Open | |
| 15 Sep 1995 | 90163219 | Societe Generale Maker Chamber Iv | ₹8 Cr | Open |
Total charge records: 4 View all charges
Deals & funding
Zoetis Pharmaceutical Research Private Limited has 3 deals on record (2 funding rounds, 1 secondary share transfer), with disclosed funding of ₹1,127.66 Cr; the latest was in November 2012.
Deals on record (3 of 3)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Nov 2012 | Funding round | ₹770.16 Cr | Investors: Pah India Holding 1 BV |
| Nov 2012 | Secondary share transfer | Undisclosed | Buyer: Pah India Holding 1 BV Seller: Pfizer Luxembourg SARL, Warner Lambert Co LLC |
| Jan 2010 | Funding round | ₹357.5 Cr | Investors: Pfizer Luxembourg SARL |
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
Zoetis Pharmaceutical Research Private Limited has 11 court cases on record: 9 filed by Zoetis Pharmaceutical Research, 2 filed against it. 2 cases are pending and 9 are disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| High courts | 9 | 1 | 2 |
| District courts | 2 | 1 | 0 |
Cases on record (5 of 11)
| Court | Type of case | Party | Status |
|---|---|---|---|
| High Court, GUJARAT | Court case (SCR.A) | Filed by the company against Parth Parenteral Pvt Ltd Thro Shailesh Ramprasad Chaturvedi and 1 other | Disposed |
| Bombay High Court | Writ petition | Filed by the company against Union of India | Pending |
| Bombay High Court | Tax appeal | Filed against the company by Pr.Commissioner of Income -Tax-11 | Pending |
| Bombay High Court | Interim or miscellaneous application | Filed by the company against an individual | Disposed |
| Bombay High Court | Court case (COMSS) | Filed by the company against an individual | Disposed |
To see the full case history of Zoetis Pharmaceutical Research Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
Zoetis Pharmaceutical Research Private Limited has 6 MSME Form 1 returns on record between 2019 and 2024, listing 43 overdue payments to 17 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.
Suppliers with reported dues (5 of 17)
| Supplier | Amount due | Due since | Reported on |
|---|---|---|---|
| Yesh Prabha Clearing & Forwarding | |||
| Precision Instrumentation and Services Private Limited | |||
| Neel Industrial Solutions Private Limited | |||
| Senergy Consultants Private Limited | |||
| Agilent Technologies India Pvt Ltd |
To see the full MSME payment records of Zoetis Pharmaceutical Research Private Limited, buy the company report.
Individuals and sole proprietors among the suppliers are not named.
Group structure & subsidiaries
Zoetis Pharmaceutical Research has 1 subsidiary company. This group structure data is as of FY 2023. The table lists each entity with its relationship and holding.
| Company Name | CIN | Shares held |
|---|---|---|
| Zoetis India Limited | U93000MH2007PLC203686 |
To see the full group structure of Zoetis Pharmaceutical Research Private Limited, buy the company report.
Employees & EPFO
Zoetis Pharmaceutical Research Private Limited has a workforce of 53 employees on its EPFO records as of Apr 07, 2024, across 1 active EPFO establishment.
GST
Zoetis Pharmaceutical Research has 4 GST registrations: 1 active and 3 cancelled or inactive.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AADCP5293L2ZV | Maharashtra | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Zoetis Pharmaceutical Research Private Limited, buy the company report.
Recent activity
Zoetis Pharmaceutical Research Private Limited has 21 board changes on record since 2007: 4 appointments and 17 cessations. The latest: Anurag Sood was appointed as Whole-Time Director on 06 Mar 2023.
16 earlier events are in the company report.
Frequently asked questions
Zoetis Pharmaceutical Research is an active foreign private limited company based in Mumbai, Maharashtra, India. The company works in pharma contract r and d, within the pharma industry. It was incorporated on 02 January 1995 (31+ years old) and is registered under CIN U24117MH1995FTC084206.
Zoetis Pharmaceutical Research has 4 current directors:
- Anurag Sood - Whole-Time Director
- Sudeepta Neogi - Whole-Time Director
- Deepak Mohanlal Jain - Whole-Time Director
- Kavita Kirankumar Bhavnani - Director
The latest financial statements of Zoetis Pharmaceutical Research on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2024. Year-wise statements from 2015 are in the company report.
The GSTIN of Zoetis Pharmaceutical Research is 27AADCP5293L2ZV, registered in Maharashtra. The company has 4 GST registrations in all, of which 1 is active and 3 are cancelled or inactive.
The CIN (Corporate Identification Number) of Zoetis Pharmaceutical Research is U24117MH1995FTC084206. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Zoetis Pharmaceutical Research has 11 court cases on record: 9 filed by the company and 2 filed against it. 2 are pending. Most are in the high courts.
Zoetis Pharmaceutical Research was incorporated on 02 January 1995, making it 31+ years old. It is registered with the Registrar of Companies, Mumbai.
Zoetis Pharmaceutical Research has 3 deals on record (2 funding rounds, 1 secondary share transfer), with disclosed funding of ₹1,127.66 Cr; the latest was in November 2012.
Anurag Sood was appointed as Whole-Time Director on 06 Mar 2023. Deepak Mohanlal Jain was appointed as Whole-Time Director on 14 Nov 2022. Deepak Mohanlal Jain ceased to be Additional Director on 14 Nov 2022. Zoetis Pharmaceutical Research has 21 board changes on record in total.
Zoetis Pharmaceutical Research has 6 MSME Form 1 returns on record between 2019 and 2024, listing 43 overdue payments to 17 micro and small suppliers. The latest return was filed on 26 Apr 2024.
Zoetis Pharmaceutical Research can be reached through the website zoetis.in. Its registered office is in Mumbai, Maharashtra, India.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
